- Erratum in:
- J Toxicol Clin Toxicol. 2004;42(7):1000.
- Comment in:
- Clin Toxicol (Phila). 2005;43(1):11-2.
- Clin Toxicol (Phila). 2005;43(1):13-5.
- Clin Toxicol (Phila). 2005;43(2):129-30.
Position paper: Ipecac syrup.
[No authors listed]Syrup of ipecac should not be administered routinely in the management of poisoned patients. In experimental studies the amount of marker removed by ipecac was highly variable and diminished with time. There is no evidence from clinical studies that ipecac improves the outcome of poisoned patients and its routine administration in the emergency department should be abandoned. There are insufficient data to support or exclude ipecac administration soon after poison ingestion. Ipecac may delay the administration or reduce the effectiveness of activated charcoal, oral antidotes, and whole bowel irrigation. Ipecac should not be administered to a patient who has a decreased level or impending loss of consciousness or who has ingested a corrosive substance or hydrocarbon with high aspiration potential. A review of the literature since the preparation of the 1997 Ipecac Syrup Position Statement revealed no new evidence that would require a revision of the conclusions of that Statement.
PMID: 15214617 [PubMed - indexed for MEDLINE]
-
Cited by 5 PubMed Central articles
-
ReviewManagement of acute organophosphorus pesticide poisoning.
Eddleston M, Buckley NA, Eyer P, Dawson AH.
Lancet. 2008 Feb 16; 371(9612):597-607.
[Lancet. 2008]
-
Study protocol: a randomised controlled trial of multiple and single dose activated charcoal for acute self-poisoning.
Eddleston M, Juszczak E, Buckley NA, Senarathna L, Mohammed F, Allen S, Dissanayake W, Hittarage A, Azher S, Jeganathan K, et al.
BMC Emerg Med. 2007 May 11; 7:2. Epub 2007 May 11.
[BMC Emerg Med. 2007]
-
Pralidoxime for organophosphate poisoning.
Eyer P, Buckley N.
Lancet. 2006 Dec 16; 368(9553):2110-1.
[Lancet. 2006]
- » See all...